LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway
Apoptosis · 2024
DOI: 10.1007/s10495-024-01963-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2024. Verfasst von Enze Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. Hauptthemen laut MEDLINE: Autophagy, Ferroptosis, Myocytes, Smooth Muscle, Phenotype. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China,China.
Abstract (Originalsprache)
Hypoxic pulmonary hypertension (HPH) is a pathophysiological syndrome in which pulmonary vascular pressure increases under hypoxic stimulation and there is an urgent need to develop emerging therapies for the treatment of HPH. LncRNA MIR210HG is a long non-coding RNA closely related to hypoxia and has been widely reported in a variety of tumor diseases. But its mechanism in hypoxic pulmonary hypertension is not clear. In this study, we identified for the first time the potential effect of MIR210HG on disease progression in HPH. Furthermore, we investigated the underlying mechanism through which elevated levels of MIR210HG promotes the transition from a contractile phenotype to a synthetic phenotype in PASMCs under hypoxia via activation of autophagy-dependent ferroptosis pathway. While overexpression of HIF-2α in PASMCs under hypoxia significantly reversed the phenotypic changes induced by MIR210HG knockdown. We further investigated the potential positive regulatory relationship between STAT3 and the transcription of MIR210HG in PASMCs under hypoxic conditions. In addition, we established both in vivo and in vitro models of HPH to validate the differential expression of specific markers associated with hypoxia. Our findings suggest a potential mechanism of LncRNA MIR210HG in the progression of HPH and offer potential targets for disease intervention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
- Department of Infectious Diseases, Hefei Second People's Hospital, Hefei, 230001, China.
- Department of Occupational Disease, Hefei Third Clinical College of Anhui Medical University, Hefei, 230022, China. zhousijing@yeah.net.
- Department of Pulmonary and Critical Care Medicine, Dushu Lake Hospital, Affiliated to Soochow University, Medical Center of Soochow University, Suzhou, 215006, China. zengdxsz@126.com.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China. wangran@ahmu.edu.cn.
Förderung
- National Natural Science Foundation of China,China
Zitieren
APA
Wang, E., Zhang, B., Huang, L., Li, P., Han, R., Zhou, S., Zeng, D., & Wang, R. (2024). LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway. Apoptosis. https://doi.org/10.1007/s10495-024-01963-4
Vancouver
Wang E, Zhang B, Huang L, Li P, Han R, Zhou S, et al. LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway. Apoptosis. 2024. doi:10.1007/s10495-024-01963-4
BibTeX
@article{Wang2024,
author = {Wang, Enze and Zhang, Binbin and Huang, Ling and Li, Pulin and Han, Rui and Zhou, Sijing and Zeng, Daxiong and Wang, Ran},
title = {LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway},
journal = {Apoptosis},
year = {2024},
doi = {10.1007/s10495-024-01963-4}
}
EUVIMED